1FDA slaps down Bristol-Myers'marketing pitch for hep C drug daclatasvir(OL)http://www.fiercebiotech,com/story/fda-slaps-down-bristol-myers-marketing-pitch-hep-cdrug-daclatas virl2014-11-26.[2014-11-26].
2Japan Approves First All-Oral,Interferon-and Ribavirin-Free Hepatitis C Treatment,Daklinza?(daclatasvir)and Sunvepra~?(asunaprevir)Dual Regimen[OL].http://news.bms.com/press-release/japan-approves-first-all-oral-interferon-and-ribavirin-freehepatitis-c-treatment-dakl.[2014-07-07].
3Bristol-Myers Squibb Company(BMY)'s Hepatitis C Drug to Lose Special Breakthrough Status From the FDA[OL]http://www.biospace.com/News/bristol-myers-squibb-companyshepatitis-c-drug-tol364112.(2015-10-02).
